[Therapy of Marchiafava-Micheli's disease: Remission under therapy with Lynestrenol (author's transl)].
The remission of a case of Marchiafava-Micheli under therapy with Lynestrenol is represented. The observation period is 16 months. The therapeutical purpose--stabilizing the red cell membrane by increasing the serum cholesterol concentration--is discussed by laboratory findings. Moreover the clinical picture and other common treatments against this disease are demonstrated by the example of this case.
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006452:Hemoglobinometry; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy*; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D012075:Remission, Spontaneous
D008234:Lynestrenol
Therapeutische Erwägungen beim Morbus Marchiafava-Micheli. Bericht einer Remission unter Lynestrenol.